Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c

Jasper Therapeutics (NASDAQ: JSPR) reported Q2 EPS of ($0.10), $0.18 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Jasper Therapeutics (JSPR) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• 374Water Inc (SCWO) Misses Q2 EPS by 15c
• Vista Oil & Gas, S.A.B. de C.V. (VIST) 1300 contracts of December 85 puts trade